JP2023526895A5 - - Google Patents

Info

Publication number
JP2023526895A5
JP2023526895A5 JP2022563230A JP2022563230A JP2023526895A5 JP 2023526895 A5 JP2023526895 A5 JP 2023526895A5 JP 2022563230 A JP2022563230 A JP 2022563230A JP 2022563230 A JP2022563230 A JP 2022563230A JP 2023526895 A5 JP2023526895 A5 JP 2023526895A5
Authority
JP
Japan
Prior art keywords
rna
vlp
cells
protein
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526895A (ja
Filing date
Publication date
Priority claimed from EP20169787.7A external-priority patent/EP3896077A1/en
Application filed filed Critical
Publication of JP2023526895A publication Critical patent/JP2023526895A/ja
Publication of JP2023526895A5 publication Critical patent/JP2023526895A5/ja
Pending legal-status Critical Current

Links

JP2022563230A 2020-04-16 2021-03-09 インフルエンザウイルス様粒子(vlp) Pending JP2023526895A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20169787.7 2020-04-16
EP20169787.7A EP3896077A1 (en) 2020-04-16 2020-04-16 Influenza virus-like particles (vlps)
PCT/EP2021/055928 WO2021209199A1 (en) 2020-04-16 2021-03-09 Influenza virus-like particles (vlps)

Publications (2)

Publication Number Publication Date
JP2023526895A JP2023526895A (ja) 2023-06-26
JP2023526895A5 true JP2023526895A5 (https=) 2024-01-31

Family

ID=70292827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563230A Pending JP2023526895A (ja) 2020-04-16 2021-03-09 インフルエンザウイルス様粒子(vlp)

Country Status (12)

Country Link
US (1) US20230201336A1 (https=)
EP (2) EP3896077A1 (https=)
JP (1) JP2023526895A (https=)
KR (1) KR20230004675A (https=)
CN (1) CN115427430A (https=)
AU (1) AU2021256266A1 (https=)
BR (1) BR112022020997A2 (https=)
CA (1) CA3172492A1 (https=)
IL (1) IL297272A (https=)
MX (1) MX2022012947A (https=)
WO (1) WO2021209199A1 (https=)
ZA (1) ZA202210419B (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278621T5 (es) 1999-07-14 2011-02-02 Mount Sinai School Of Medicine Of New York University Reconstrucción in vitro de virus arn segmentados de polaridad negativa.
US20070116717A1 (en) 2005-08-01 2007-05-24 Shneider Alexander M Influenza vaccine compositions and methods
CN102373181B (zh) * 2010-08-09 2014-06-11 中山大学 猪流感病毒和猪蓝耳病病毒混合病毒样颗粒、制备方法和应用
US9150620B2 (en) * 2012-04-18 2015-10-06 National Tsing Hua University Vaccine against multitypes of avian influenza viruses and uses thereof
HK1208355A1 (en) * 2012-11-05 2016-03-04 Georgia State University Research Foundation, Inc. Universal influenza vaccine based on heterologous multiple m2e proteins
US10369216B2 (en) 2014-04-01 2019-08-06 Curevac Ag Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
US10494613B2 (en) * 2015-08-28 2019-12-03 Wisconsin Alumni Research Foundation (Warf) Generation of infectious influenza viruses from virus-like particles
EP3814509A4 (en) 2018-06-27 2022-07-27 Medicago Inc. INFLUENCE VIRUS HEMAGGLUTININ MUTANTS
WO2020014656A1 (en) 2018-07-13 2020-01-16 University Of Georgia Research Foundation Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP7575012B2 (ja) 卵における複製のための安定化されたhaを有する組換えインフルエンザウイルス
JP7297832B2 (ja) ウイルス様粒子からの感染性インフルエンザウイルスの生成
US8597661B2 (en) Neuraminidase-deficient live influenza vaccines
EP1631663B1 (en) High titer recombinant influenza viruses for vaccines and gene therapy
JP2022066209A (ja) Mdck、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス
US20240076632A1 (en) Recombinant influenza viruses with stabilized ha for replication in eggs
EP2493912B1 (en) High titer recombinant influenza viruses with enhanced replication in vero cells
JP2019510481A (ja) ワクチン開発のための改善されたb型インフルエンザウイルス複製
CN101365479A (zh) 呈现非天然表面蛋白的嵌合病毒及其应用
JP2008520248A (ja) タンデム転写ユニットを有する組換えインフルエンザベクター
CA2991023C (en) Attenuated influenza vectors used for the prevention and/or treatment of infectious diseases as well as for the treatment of oncological diseases
WO2017007839A1 (en) Improved influenza virus replication for vaccine development
JP2021518152A5 (https=)
JP2023526895A5 (https=)
CN110573614A (zh) 针对流感的免疫原性组合物
KR102091281B1 (ko) 재조합 인플루엔자 a 바이러스 h5n6주 및 이를 포함하는 고병원성 인플루엔자 a 바이러스 백신 조성물
KR102182987B1 (ko) 재조합 인플루엔자 a 바이러스 h5n1주 및 이를 포함하는 고병원성 인플루엔자 a 바이러스 백신 조성물
CN110573613A (zh) 流感b病毒突变体及其用途
US20170274064A1 (en) Modified bat influenza viruses and their uses
TW202609053A (zh) 類病毒顆粒、其製備方法及其用於製備疫苗之用途
CN114980921A (zh) 新型初免-加强流感疫苗
HK1082769B (en) High titer recombinant influenza viruses for vaccines and gene therapy
HK1127731B (en) Chimeric viruses presenting non-native surface proteins and uses thereof